Marathon Flow Directed Micro Catheter, Model #105-5055. Product Usage: The Marathon Flow Direc...

FDA Device Recall #Z-2472-2012 — Class II — September 23, 2011

Recall Summary

Recall Number Z-2472-2012
Classification Class II — Moderate risk
Date Initiated September 23, 2011
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Micro Therapeutics Inc, Dba Ev3 Neurovascular
Location Irvine, CA
Product Type Devices
Quantity 23 units total

Product Description

Marathon Flow Directed Micro Catheter, Model #105-5055. Product Usage: The Marathon Flow Directed Micro Catheter is intended to access the peripheral and neuro vasculature for the controlled selective infusion of physician-specified therapeutic agents such as embolization materials and of diagnostic materials such as contrast media.

Reason for Recall

The recall was initiated because ev3 Neurovascular has identified one lot of UltraFlow Flow Directed Micro Catheters and Marathon Flow Directed Micro Catheters may have been mislabeled.

Distribution Pattern

Worldwide Distribution - US Nationwide including the states: MN, FL, OR, TX and the countries of: Brazil, Belgium, Czech Republic, Finlind, France, Germany, Netherlands, Poland, and United Kingdom.

Lot / Code Information

Lot # 9374210

Other Recalls from Micro Therapeutics Inc, Dba Ev3 Neuro...

Recall # Classification Product Date
Z-1527-2020 Class I ev3 Pipeline Flex Embolization Device. For neu... Feb 14, 2020
Z-1528-2020 Class I ev3 Pipeline Flex Embolization Device with Shie... Feb 14, 2020
Z-3022-2018 Class II ev3 TurboHawk PERPHERAL PLAQUE EXCISION SYSTEM ... Aug 10, 2018
Z-1701-2018 Class I MindFrame Capture LP Revascularization Devices:... Feb 26, 2018
Z-0309-2017 Class I Marathon Flow Directed Micro Catheter, UltraFlo... Oct 5, 2016

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.